Workshop on the clinical investigation of new medicines for the treatment of multiple sclerosis

Date: 17/10/2013
Location: European Medicines Agency, London, UK

The main goal of the workshop is to make sure that in the revision of the multiple-sclerosis guideline, the European Medicines Agency can take the most up-to-date, state-of-the-art scientific developments in multiple sclerosis into consideration, as well as the positions of experts in the field on the main topics in the guideline.



How useful was this page?

Add your rating
1 rating